193 related articles for article (PubMed ID: 25510805)
21. Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience.
Gaviani P; Simonetti G; Salmaggi A; Lamperti E; Silvani A
J Neurooncol; 2013 Jul; 113(3):527-9. PubMed ID: 23703296
[No Abstract] [Full Text] [Related]
22. Low-grade glioma.
Kumthekar P; Raizer J; Singh S
Cancer Treat Res; 2015; 163():75-87. PubMed ID: 25468226
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.
Bouffet E; Jakacki R; Goldman S; Hargrave D; Hawkins C; Shroff M; Hukin J; Bartels U; Foreman N; Kellie S; Hilden J; Etzl M; Wilson B; Stephens D; Tabori U; Baruchel S
J Clin Oncol; 2012 Apr; 30(12):1358-63. PubMed ID: 22393086
[TBL] [Abstract][Full Text] [Related]
24. Prediction of response to chemotherapy in anaplastic glioma: how many markers does it take?
de Groot JF
J Clin Oncol; 2013 Jan; 31(3):297-8. PubMed ID: 23269985
[No Abstract] [Full Text] [Related]
25. [Genetic analysis and individualized therapy for diffuse glioma].
Watanabe T; Yoshino A; Katayama Y
No Shinkei Geka; 2005 Jun; 33(6):537-53. PubMed ID: 15952303
[No Abstract] [Full Text] [Related]
26. Optic pathway gliomas.
Avery RA; Fisher MJ; Liu GT
J Neuroophthalmol; 2011 Sep; 31(3):269-78. PubMed ID: 21857190
[TBL] [Abstract][Full Text] [Related]
27. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
[TBL] [Abstract][Full Text] [Related]
28. Role of tyrosine kinase inhibitors in the management of high-grade gliomas.
Ahluwalia MS; Patel M; Peereboom DM
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1739-48. PubMed ID: 22050023
[TBL] [Abstract][Full Text] [Related]
29. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy for diffuse low-grade gliomas in adults.
Ducray F
Rev Neurol (Paris); 2011 Oct; 167(10):673-9. PubMed ID: 21906770
[TBL] [Abstract][Full Text] [Related]
32. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic gliomas: radiation, chemotherapy, or both?
Blondin NA; Becker KP
Hematol Oncol Clin North Am; 2012 Aug; 26(4):811-23. PubMed ID: 22794285
[TBL] [Abstract][Full Text] [Related]
34. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of gene expression profiles in malignant brain tumors with respect to sensitivity to therapies].
Yamanaka R; Morii K; Takahashi H; Tanaka R; Nishio K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():49-54. PubMed ID: 16201499
[No Abstract] [Full Text] [Related]
36. [Inhibition of cellular adhesion and invasion in gliomas].
Sasaki H; Yoshida K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():68-73. PubMed ID: 16201502
[No Abstract] [Full Text] [Related]
37. Multi-agent cytostatic treatment of 'low-grade' gliomas.
Linskey ME
Curr Oncol Rep; 2000 Sep; 2(5):454-62. PubMed ID: 11122878
[TBL] [Abstract][Full Text] [Related]
38. Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.
Lukas RV; Amidei C
Tumori; 2014; 100(3):358-62. PubMed ID: 25076251
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy for malignant brain tumors of childhood.
Gottardo NG; Gajjar A
J Child Neurol; 2008 Oct; 23(10):1149-59. PubMed ID: 18952581
[TBL] [Abstract][Full Text] [Related]
40. On high-risk, low-grade glioma: What distinguishes high from low?
Geurts M; van den Bent MJ
Cancer; 2019 Jan; 125(2):174-176. PubMed ID: 30512190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
